Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BMS-986235 (LAR-1219) | 2253947-47-4 | 99.7% | 500 MG
SDP

Catalog No. 5000339827
Encompass_Preferred

BMS-986235 (LAR-1219) is a selective, orally active formyl peptide receptor 2 (FPR2) agonist, with EC50s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively. BMS-986235 has potential for the prevention of heart failure.

  • It inhibits neutrophil chemotaxis and stimulates macrophage phagocytosis, key endpoints to promote resolution of inflammation.
  • It can attenuate left ventricle and global cardiac remodeling after left anterior descending (LAD) in mice (0.3 mg/kg; p.o.; daily for 24 days).
  • Treatment shows the Cmax, T1/2, AUC0-inf, and bioavailability (BA) values of 160 nmol/L, 0.68 hours, 120 nmol/L·h, and 24%, respectively (1 mg/kg; p.o.).

Catalog No. 50-003-39827 Supplier Medchemexpress LLC Supplier No. HY131180500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BMS-986235 (LAR-1219) is a selective, orally active formyl peptide receptor 2 (FPR2) agonist, with EC50s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively. BMS-986235 has potential for the prevention of heart failure.

  • It inhibits neutrophil chemotaxis and stimulates macrophage phagocytosis, key endpoints to promote resolution of inflammation.
  • It can attenuate left ventricle and global cardiac remodeling after left anterior descending (LAD) in mice (0.3 mg/kg; p.o.; daily for 24 days).
  • Treatment shows the Cmax, T1/2, AUC0-inf, and bioavailability (BA) values of 160 nmol/L, 0.68 hours, 120 nmol/L·h, and 24%, respectively (1 mg/kg; p.o.).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.